Article Type
Changed
Tue, 05/03/2022 - 15:52
Display Headline
Just over a third of hypertensive kidney patients are at target BP

AMSTERDAM – Eighty percent of Americans with chronic kidney disease have comorbid hypertension, which is controlled in only 36% of cases, according to a large national study.

This is an area of significant unmet medical need in spite of the wide availability of antihypertensive medications, Panagiotis Mavros, Ph.D., said at the annual congress of the European Society of Cardiology.

He presented a cross-sectional study involving 159,306 American adults with stage 1-4 chronic kidney disease (CKD) identified in the GE Centricity electronic medical record database. Fifty-seven percent were in stage 3 and 29% were in stage 2 CKD.

Roughly 43% of this very large group of CKD patients carried the diagnosis of diabetes mellitus. Eighty percent of the CKD population had hypertension, including 10% of the overall study population with previously undiagnosed hypertension. Among the CKD patients with hypertension, 15% were not being treated for it, said Dr. Mavros of Merck in Whitehouse Station, N.J.

Blood pressure was controlled to the target of less than 130/80 mm Hg in 36% of patients with diagnosed hypertension.

Seventy-three percent of treated hypertensive patients with CKD were on combination therapy, typically with three different classes of antihypertensive drugs. Patients on more than three different classes of antihypertensive medications tended to have more advanced CKD. However, the proportion of treated patients with good blood pressure control did not differ according to CKD stage.

This cross-sectional study was funded by Merck. Dr. Mavros is a full-time company employee.

bjancin@frontlinemedcom.com

Meeting/Event
Author and Disclosure Information

Publications
Topics
Legacy Keywords
chronic kidney disease, hypertension
Sections
Author and Disclosure Information

Author and Disclosure Information

Meeting/Event
Meeting/Event

AMSTERDAM – Eighty percent of Americans with chronic kidney disease have comorbid hypertension, which is controlled in only 36% of cases, according to a large national study.

This is an area of significant unmet medical need in spite of the wide availability of antihypertensive medications, Panagiotis Mavros, Ph.D., said at the annual congress of the European Society of Cardiology.

He presented a cross-sectional study involving 159,306 American adults with stage 1-4 chronic kidney disease (CKD) identified in the GE Centricity electronic medical record database. Fifty-seven percent were in stage 3 and 29% were in stage 2 CKD.

Roughly 43% of this very large group of CKD patients carried the diagnosis of diabetes mellitus. Eighty percent of the CKD population had hypertension, including 10% of the overall study population with previously undiagnosed hypertension. Among the CKD patients with hypertension, 15% were not being treated for it, said Dr. Mavros of Merck in Whitehouse Station, N.J.

Blood pressure was controlled to the target of less than 130/80 mm Hg in 36% of patients with diagnosed hypertension.

Seventy-three percent of treated hypertensive patients with CKD were on combination therapy, typically with three different classes of antihypertensive drugs. Patients on more than three different classes of antihypertensive medications tended to have more advanced CKD. However, the proportion of treated patients with good blood pressure control did not differ according to CKD stage.

This cross-sectional study was funded by Merck. Dr. Mavros is a full-time company employee.

bjancin@frontlinemedcom.com

AMSTERDAM – Eighty percent of Americans with chronic kidney disease have comorbid hypertension, which is controlled in only 36% of cases, according to a large national study.

This is an area of significant unmet medical need in spite of the wide availability of antihypertensive medications, Panagiotis Mavros, Ph.D., said at the annual congress of the European Society of Cardiology.

He presented a cross-sectional study involving 159,306 American adults with stage 1-4 chronic kidney disease (CKD) identified in the GE Centricity electronic medical record database. Fifty-seven percent were in stage 3 and 29% were in stage 2 CKD.

Roughly 43% of this very large group of CKD patients carried the diagnosis of diabetes mellitus. Eighty percent of the CKD population had hypertension, including 10% of the overall study population with previously undiagnosed hypertension. Among the CKD patients with hypertension, 15% were not being treated for it, said Dr. Mavros of Merck in Whitehouse Station, N.J.

Blood pressure was controlled to the target of less than 130/80 mm Hg in 36% of patients with diagnosed hypertension.

Seventy-three percent of treated hypertensive patients with CKD were on combination therapy, typically with three different classes of antihypertensive drugs. Patients on more than three different classes of antihypertensive medications tended to have more advanced CKD. However, the proportion of treated patients with good blood pressure control did not differ according to CKD stage.

This cross-sectional study was funded by Merck. Dr. Mavros is a full-time company employee.

bjancin@frontlinemedcom.com

Publications
Publications
Topics
Article Type
Display Headline
Just over a third of hypertensive kidney patients are at target BP
Display Headline
Just over a third of hypertensive kidney patients are at target BP
Legacy Keywords
chronic kidney disease, hypertension
Legacy Keywords
chronic kidney disease, hypertension
Sections
Article Source

AT THE ESC CONGRESS 2013

PURLs Copyright

Inside the Article

Vitals

Major finding: Of a large group of patients with chronic kidney disease and comorbid hypertension, 36% were at the blood pressure goal of less than 130/80 mm Hg.

Data source: A cross-sectional study involving more than 159,000 U.S. adults with stage 1-4 chronic kidney disease, 80% of whom had comorbid hypertension.

Disclosures: The study was funded by Merck. The presenter is a full-time employee of the pharmaceutical company.